000			01292 a2200385 4500
005			20250515232113.0
264		0	_c20100804
008			201008s 0 0 ger d
022			_a1438-3276
040			_aNLM _beng _cNLM
100	1		_aMärz, Winfried
245	0	0	_a[C-reactive protein and coronary heart disease: quo vadis?]. _h[electronic resource]
260			_bMMW Fortschritte der Medizin _cOct 2009
300			_a127-32 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAlleles
650	0	4	_aApolipoproteins E _xgenetics
650	0	4	_aC-Reactive Protein _xgenetics
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aCoronary Artery Disease _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFluorobenzenes _xtherapeutic use
650	0	4	_aHaplotypes _xgenetics
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aMale
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aRisk Factors
650	0	4	_aRosuvastatin Calcium
650	0	4	_aStroke _xdrug therapy
650	0	4	_aSulfonamides _xtherapeutic use
700	1		_aGrammer, Tanja B
773	0		_tMMW Fortschritte der Medizin _gvol. 151 Suppl 3 _gp. 127-32
999			_c19967012 _d19967012